. 2008 Dec 18;32(3):424–435. doi: 10.1007/s00270-008-9472-8

Table 2.

Patient demographic distribution and patient baseline data at randomization in the AMS INSIGHT

	PTA only	AMS	p-value
Age
Mean ± SD year	73.1 ± 8.5	74.7 ± 7.8	0.31^a
N/N_total; min–max	57/117; 53–91	60/117; 55–87
Male, N/N_total (%)	41/57 (71.9)	31/60 (51.7)	0.04^b
Female, N/N_total (%)	16/57 (28.1)	29/60 (48.3)	0.04^b
Diabetes mellitus, N/N_total (%)	39/57 (68.4)	43/60 (71.7)	0.84^b
Smoking, N/N_total (%)	26/57 (45.6)	24/60 (40.0)	0.58^b
Hyperlipidemia, N/N_total (%)	35/57 (61.4)	32/60 (53.3)	0.45^b
Hypertension, N/N_total (%)	51/57 (89.5)	51/60 (85.0)	0.58^b
Rutherford category, N/N_total (%)
4	16/57 (28.1)	16/60 (26.7)	0.87^c
5	41/57 (71.9)	44/60 (73.3)	0.87^c
Ankle-brachial index
Mean ± SD (N)	0.7 ± 0.3 (44)	0.8 ± 0.5 (46)	0.21^a
Min–max	0.2–1.8	0.3–2.5	0.21^a

Note: PTA, percutaneous transluminal angioplasty; AMS, absorbable metal stent

^at-test

^bFisher exact test

^cWilcoxon test